Back to Results
First PageMeta Content
Immunotherapy / Prostate cancer / Leukapheresis / Neuvenge / Medicine / Dendreon / Immunology


HIGHLIGHTS OF PRESCRIBING INFORMATION
Add to Reading List

Open Document

File Size: 236,92 KB

Share Result on Facebook

Company

Cox / SUSPECTED ADVERSE REACTIONS / Dendreon Corporation / 23 Dendreon Corporation / /

Event

FDA Phase / /

IndustryTerm

final product / healthcare professional / treatment of metastatic castrate resistant prostate cancer / autologous active cellular immunotherapy product / immunotherapy products / /

MedicalCondition

tumor / Insomnia / ventricular tachycardia / hypertension / bronchospasm / cancer / headache / Arthralgia / dyspnea / chills / sterility / Musculoskeletal chest pain / Hematuria / Urinary tract infection / prostate cancers / cardiac arrhythmias / pulmonary conditions / Muscle spasms / nausea / hyperhidrosis / infectious sequelae / fever / rhabdomyolysis / Tremor / transmissible infectious diseases / dependent prostate cancer / vomiting / Pain / fatigue / myositis / diseases / infectious diseases / preliminary sterility / tachycardia / display tumor / Diarrhea / atrial fibrillation / dizziness / Cough / prostate cancer / resistant prostate cancer / illness / Constipation / infections / Rash / Back pain / influenza / paresthesia / respiratory tract infection / Anemia / eosinophilia / sepsis / myasthenia gravis / /

MedicalTreatment

Leukapheresis / catheters / Immunosuppressive Therapy / chemotherapy / Intravenous Infusion / immunotherapy / /

Organization

DOSAGE AND ADMINISTRATION / FDA / /

/

Position

Physician / General / /

Product

acetaminophen / PROVENGE® / /

Technology

chemotherapy / /

URL

www.fda.gov/medwatch / /

SocialTag